Arvinder Singh Pasricha acquires 51.12 percent stake in Ador Multiproducts

NOOR MOHMMED

    19/May/2025

  • Arvinder Singh Pasricha and his associates acquired 48,87,356 shares in Ador Multiproducts, representing 51.12 percent of expanded capital.

  • The acquisition occurred via preferential allotment at a price of INR 31.41 per share, as disclosed under SEBI Regulation 18(6).

  • Post-acquisition, the total holding of acquirers and PACs rose to 55.16 percent of Ador Multiproducts’ expanded share capital.

Arvinder Singh Pasricha, along with persons acting in concert (PAC), has acquired a controlling stake in Ador Multiproducts Limited by purchasing 48,87,356 equity shares, constituting 51.12% of the company’s expanded share capital. The disclosure, made under Regulation 18(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, was submitted to BSE Limited on May 16, 2025.

The acquisition was executed through a preferential allotment of shares by Ador Multiproducts at an issue price of INR 31.41 per share, which includes a premium over the face value of INR 10 per share. The shares were allotted on May 16, 2025, increasing the total paid-up share capital of the company to INR 9,56,09,890, divided into 95,60,989 equity shares.

Key Participants in the Acquisition

The acquirers named in the disclosure include:

  • Mr. Arvinder Singh Pasricha

  • Mrs. Aman Pasricha Balsara

  • Ms. Zinnia Pasricha

  • Thrive Future Habitats Infra Private Limited

The PAC (person acting in concert) in this acquisition is:

  • Mr. Tushar Rohinton Balsara

Among the acquirers, Mr. Arvinder Singh Pasricha and Mrs. Aman Pasricha Balsara were the direct recipients of the preferential allotment, acquiring a total of 48,87,356 equity shares on May 16, 2025.

Prior to this acquisition, the acquirers and PACs together held 3,86,054 shares, representing 8.26% of the pre-issue share capital. With this preferential allotment, their total holding rose to 52,73,410 shares, or 55.16% of the expanded capital, thereby triggering the need to file disclosures under the SEBI SAST Regulations.

Details of the Acquisition

Acquirer Shares Acquired Mode of Acquisition Price per Share Shareholding Before Shareholding After
Mr. Arvinder Singh Pasricha 26,36,705 Preferential Allotment INR 31.41 0.00% Included in total
Mrs. Aman Pasricha Balsara 22,50,651 Preferential Allotment INR 31.41 0.00% Included in total
Combined (with PACs) 48,87,356 Preferential Allotment INR 31.41 8.26% (Pre-Issue) 55.16% (Post-Issue)

Capital Structure

  • Pre-Issue Paid-up Capital: INR 4,67,36,330 (46,73,633 shares)

  • Post-Issue (Expanded) Capital: INR 9,56,09,890 (95,60,989 shares)

The preferential issue effectively doubled the company’s equity capital, enabling the Pasricha family and associated entities to secure a majority stake.

SEBI Compliance

This transaction falls under Regulation 18(6) of the SEBI SAST Regulations, which mandates disclosure of share acquisitions during an offer period. The disclosure confirms that all acquiring parties were previously identified in the detailed public announcement as either acquirers or PACs.

The transaction does not involve a market purchase; instead, it is classified as a private placement of shares on a preferential basis, a common route for securing significant strategic or controlling stakes.

Strategic Implications

With a controlling interest exceeding 50%, Arvinder Singh Pasricha and associates now have the capacity to influence board decisions, initiate business restructuring, or direct strategic realignment of Ador Multiproducts. Such a stake acquisition could be part of a broader corporate growth strategy, potentially leading to a mandatory open offer for the remaining public shareholders, depending on regulatory thresholds and exemptions.

About Ador Multiproducts Limited


The Upcoming IPOs in this week and coming weeks are Blue Water LogisticsUnified Data - Tech SolutionsVictory Electric Vehicles InternationalBorana WeavesDar Credit and CapitalBelrise IndustriesWagons Learning.


The Closed IPOs are Accretion PharmaceuticalsIntegrity Infrabuild Developers.


Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst

Related News

Disclaimer

The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.

Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.

We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.

You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.

By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.

onlyfans leakedonlyfan leaksonlyfans leaked videos